Hypercalcemia Crisis Medical Slides
Generate publication-quality hypercalcemia crisis lecture slides in 30 seconds. AI-powered content structured for clinical education.
Generate Hypercalcemia Crisis DeckWhy teach Hypercalcemia Crisis?
Hypercalcemia crisis (calcium >14 mg/dL or symptomatic >12 mg/dL) is a medical emergency with mortality up to 50% if untreated. Primary hyperparathyroidism and malignancy account for over 90% of all hypercalcemia cases. The malignancy-associated form, mediated by PTHrP (80%), osteolytic metastases (20%), or calcitriol production (<1%), typically presents with more severe calcium elevation and carries worse prognosis. Emergency management follows a stepwise protocol of volume resuscitation, calciuresis, and anti-resorptive therapy.
What AI generates for Hypercalcemia Crisis
Enter “Hypercalcemia Crisis” and SlideCraft generates a complete lecture deck with slides like these.
See it in action
Type any medical topic and watch AI generate a presentation slide in seconds. No signup required.
3 free previews per hour · No account needed
Enter a topic and click Generate to see your AI slide
Hypercalcemia Crisis Presentation FAQ
How should the emergency treatment sequence be presented in hypercalcemia crisis?
Present the time-based sequence: IMMEDIATE (hours 0-4) — aggressive IV NS 200-500 mL/hr (patients are profoundly volume-depleted from hypercalcemia-induced nephrogenic DI; may need 4-6 L in first 24 hours). Calcitonin 4 IU/kg IM/SC every 12 hours (onset 4-6 hours, reduces calcium 1-2 mg/dL, but tachyphylaxis by 48 hours). INTERMEDIATE (hours 0-24) — zoledronic acid 4 mg IV over 15 min (onset 2-4 days, peak effect 4-7 days, duration 2-4 weeks) OR pamidronate 60-90 mg IV over 2-4 hours. Do NOT use loop diuretics routinely — only after volume repletion and only if volume overload develops. Monitor calcium, electrolytes, and renal function every 6-12 hours.
What etiology workup algorithm should be included?
Present the PTH-based algorithm: Check intact PTH (first branch point). PTH elevated/inappropriately normal → primary hyperparathyroidism (most common outpatient cause), familial hypocalciuric hypercalcemia (check calcium-creatinine clearance ratio <0.01), lithium-induced, tertiary hyperparathyroidism. PTH suppressed (<20 pg/mL) → check PTHrP, 1,25-dihydroxy vitamin D, 25-hydroxy vitamin D, SPEP/UPEP. PTHrP elevated → humoral hypercalcemia of malignancy (lung, renal, breast common). 1,25(OH)2D elevated → granulomatous disease (sarcoidosis) or lymphoma. 25(OH)D elevated → vitamin D intoxication. Normal PTHrP and vitamin D with malignancy → osteolytic metastases (breast, myeloma, lung).
How should refractory hypercalcemia management be taught?
Present options for bisphosphonate-refractory hypercalcemia: Denosumab 120 mg SC — RANKL inhibitor, effective when bisphosphonates fail (especially in renal impairment where bisphosphonates are contraindicated or less effective). Onset 2-4 days. Risk of severe rebound hypercalcemia when discontinued. Hemodialysis — use low-calcium or calcium-free dialysate for immediately life-threatening hypercalcemia (calcium >18 mg/dL, arrhythmias, severe AKI). Reduces calcium rapidly but transiently. Cinacalcet 30-90 mg PO BID — calcimimetic, useful for parathyroid carcinoma-related hypercalcemia. Gallium nitrate and plicamycin are historical agents largely replaced by newer therapies.
Simple pricing, no surprises
Start free today. Upgrade when your department needs more.
Free
Try SlideCraft with no commitment
- 2 decks per month
- AI slides with speaker notes
- View & present only (no export)
- 7-day cloud storage
- Slide Checker & Outline Generator
Pro
For clinicians who lecture weekly
- 10 decks/mo + $2.50/extra
- AI Critic Mode (5-axis review)
- Document-to-deck (PDF upload)
- PDF, PPTX, SCORM & image export
- Permanent cloud storage
Expert
For academic physicians who publish and present
- 25 decks/mo + $2.00/extra
- PubMed source verification
- Paper-to-deck pipeline
- Auto-citations (Vancouver)
- Everything in Pro